Have you ever wondered why so many new drugs fail even after years of research and billions in investment? In this episode, we dive deep into the challenges of drug commercialization, the role of AI in pharma, and the biggest mistakes companies make before going to market.

Our guest, Dan Cummings, is a leading expert in go-to-market strategy, having worked with top health tech, medtech, and biotech startups. He shares insider insights on why even successful clinical trials don’t guarantee a product’s success and how companies can improve their chances.

We also explore:
- The shocking statistics behind drug approvals 
- Why less than a third of new drugs in 2025 will meet expectations
- The #1 mistake pharma companies make before launch 
- How AI is transforming drug development & commercialization 
- What makes some drugs cost millions of dollars, while others are much cheaper 

This episode is packed with industry insights, expert opinions, and bold predictions about the future of pharmaceuticals.

Chapters:

• 00:00 Introduction
• 03:54 The Challenges of Drug Commercialization
• 05:35 Market Access & Value-Based Pricing
• 12:00 Predictions for 2025 Drug Approvals
• 13:23 The Role of AI in Pharma
• 16:59 Why Most Drug Launches Miss Expectations
• 18:25 Lessons from Biotech Success Stories
• 23:46 The Future of Pharma & Go-to-Market Strategies
• 29:31 How Companies Can Improve Their Launch Success
• 35:56 Final Thoughts & Takeaways

🔗 Links Mentioned:
📌 Connect with Dan Cummings on LinkedIn
📌 Learn more about Envision Pharma Group


If you enjoyed this, you'll like these other past episodes:
How to Combine Storytelling and Science for Impact
Understanding Drug Pricing and the Impact of the Inflation Reduction Act

For transcripts, check out the podcast website - www.lifesciencespod.com